Data / Drug companies / Cyanocobalamin
Cyanocobalamin: 25 companies and 55 products in the FDA NDC directory
Cyanocobalamin is listed in the FDA National Drug Code Directory by 25 companies, with 55 products in commercial distribution. 53 of the products (96.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection; spray, and the newest product started marketing on June 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 25
- Products
- 55
- Generic (ANDA) products
- 53 (96.4%)
- Application numbers
- 16
- Routes
- Intramuscular, Subcutaneous, Nasal
- Brand names
- Nascobal, Non-proprietary Name
- openFDA record search
- api.fda.gov
Companies that list cyanocobalamin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | 6 | injection | Generic drugs (ANDA) | November 15, 2024 |
| HF Acquisition Co LLC, DBA HealthFirst | 4 | injection, solution; injection | Generic drugs (ANDA) | January 29, 2020 |
| American Regent, Inc. | 3 | injection, solution | Generic drugs (ANDA) | May 29, 2003 |
| Asclemed USA, Inc. | 3 | injection; injection, solution | Generic drugs (ANDA) | August 3, 2022 |
| Gland Pharma Limited | 3 | injection | Generic drugs (ANDA) | October 14, 2022 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | October 20, 1971 |
| Lifestar Pharma LLC | 3 | injection, solution | Generic drugs (ANDA) | May 1, 2026 |
| Plano Pharmaceuticals Inc. | 3 | injection | Generic drugs (ANDA) | October 14, 2022 |
| Somerset Therapeutics, LLC | 3 | injection; injection, solution | Generic drugs (ANDA) | December 18, 2018 |
| Vitruvias Therapeutics | 3 | injection, solution | Generic drugs (ANDA) | February 12, 2020 |
| Zydus Lifesciences Limited | 3 | injection, solution | Generic drugs (ANDA) | May 5, 2022 |
| Zydus Pharmaceuticals USA Inc. | 3 | injection, solution | Generic drugs (ANDA) | May 5, 2022 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | October 18, 2000 |
| Henry Schein, Inc. | 2 | injection, solution | Generic drugs (ANDA) | May 8, 2025 |
| A-S Medication Solutions | 1 | injection, solution | Generic drugs (ANDA) | January 2, 2019 |
| BluePoint Laboratories | 1 | injection, solution | Generic drugs (ANDA) | April 7, 2025 |
| Eugia US LLC | 1 | injection, solution | Generic drugs (ANDA) | December 8, 2020 |
| Lupin Pharmaceuticals,Inc. | 1 | spray, metered | Generic drugs (ANDA) | January 29, 2024 |
| NorthStar RxLLC | 1 | injection, solution | Generic drugs (ANDA) | September 1, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 1 | spray | Generic drugs (ANDA) | December 28, 2023 |
| Par Health USA, LLC | 1 | spray | New drug applications (NDA) | August 13, 2009 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Sola Pharmaceuticals, LLC | 1 | injection | Generic drugs (ANDA) | August 3, 2022 |
| Sportpharm LLC | 1 | injection | Generic drugs (ANDA) | December 11, 2015 |
| Xseer Pharmaceuticals | 1 | injection | Other unapproved drugs | June 1, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 29 | 52.7% |
| Injection | 23 | 41.8% |
| Spray | 2 | 3.6% |
| Spray, metered | 1 | 1.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 53 | 96.4% |
| New drug applications (NDA) | 1 | 1.8% |
| Other unapproved drugs | 1 | 1.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Vitamin B12 | 55 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.